Expert Interview
Discussing HAE and sebetralstat as an on-demand therapy in the KONFIDENT trial from Kalvista Pharmaceuticals
Ticker(s): KALV, PHVSInstitution: Allergy Specialists
- Board certified Internist and Allergist in private practice in Dallas, Texas treating adults and children with allergic diseases and asthma.
- Clinical Professor of Internal Medicine at the University of Texas Southwestern Medical School in Dallas and teaches at Parkland Memorial and Presbyterian Hospitals in Dallas.
- Follows 140 type 1 and 2 patients with HAE.
- Member of the U.S. Hereditary Angioedema Association and on the panel responsible for the HAWK, ICON and WAO hereditary angioedema consensus documents.
What do you think of the KONFIDENT trial design?
Added By: wilson_adminAre you confident that sebetralstat will hit on its primary endpoint?
Added By: wilson_adminHow popular would an on-demand therapy be?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
